Abstract:Recent advances in the fields of thromboinflammation and immunothrombosis induced a paradigm shift integrating platelets as key components of the immune system, independent of their hemostatic functions. Platelets constitutively express a plethora of immune receptors such as toll-like receptors (TLRs), complement receptors, antibody receptors (FcR), and intracellular NOD-like receptors (NLRs) and, upon activation, can also upregulate and secrete an arsenal of immunomodulatory molecules, regulating both the innate and adaptive immune responses [<a href="#">1</a>,<a href="#">2</a>]. Although platelets were initially shown to promote a proinflammatory and prothrombotic state in sterile and infectious injuries, recent studies have shown protective roles for platelets during inflammation, in particular in the maintenance of vascular integrity, resolution of inflammation, and promotion of tissue repair [<a href="#">3</a>,<a href="#">4</a>]. More recently, platelet microvesicles have emerged as novel regulators of thrombo-inflammatory diseases, which, unto themselves, can regulate both innate and adaptive immunity [<a href="#">5</a>,<a href="#">6</a>]. Inflammatory/immune alteration of platelet function does not occur solely in periphery, but might also result from transcriptional and translational alteration in the genetic profile of megakaryocytes. The pro- or anti-inflammatory functions of platelets are highly dynamic with distinct receptors engaged in different vascular beds during the course of the inflammatory response. Likewise, the composition and structure of thrombi under inflammatory conditions is highly heterogeneous, dictated directly by the specific nature of the insult and the characteristics of the target vascular bed/organ. Moreover, recent studies have shown significant changes in the composition of the thrombi within the same organ during disease progression, increasing the complexity of successful treatment under thromboinflammatory conditions without global alteration of the hemostatic balance. Therefore, the success of novel anti-thrombotic drugs or the strategic repurposing of existing therapies will need to be tailored to each stimulus, organ, and disease state in an effort to limit both thrombosis and inflammation while simultaneously preserving vascular integrity and organ function.

Platelet HMGB1 Steers Intravascular Immunity and Thrombosis

Platelets: key players in vascular inflammation

Platelets: Orchestrators of immunity in host defense and beyond

Platelets: bridging thrombosis and inflammation

Platelets and vascular integrity: how platelets prevent bleeding in inflammation.

Platelet Interaction with Innate Immune Cells

Emerging Role of High Mobility Group Box-1 in Thrombosis-Related Diseases

Emerging Role of High Mobility Group Box-1 in Thrombosis-Related Diseases.

Implication of Platelets in Immuno-Thrombosis and Thrombo-Inflammation

Platelets in Inflammation and Atherogenesis

Platelets and inter-cellular communication in immune responses: Dialogue with both professional and non-professional immune cells

The dual role of platelet‐innate immune cell interactions in thrombo‐inflammation

Platelet toll-like receptors in thromboinflammation.

The role of platelets in central hubs of inflammation: A literature review

Platelets in the NETworks interweaving inflammation and thrombosis

The Expression of HMGB1 on Microparticles Released during Cell Activation and Cell Death In Vitro and In Vivo

Vascular surveillance by haptotactic blood platelets in inflammation and infection

Platelet-vessel wall interactions in atherosclerotic disease

Fresh Evidence for Platelets as Neuronal and Innate Immune Cells: Their Role in the Activation, Differentiation, and Deactivation of Th1, Th17, and Tregs during Tissue Inflammation

Platelet biology and functions: new concepts and clinical perspectives

The role of platelets in the recruitment of leukocytes during vascular disease